MRSA

 

Methicillin Resistant Staphylococcus aureus, or MRSA, has been in the news a great deal lately. It is a drug resistant strain of a common bacterium found on everyone's skin. Fortunately, MRSA infections in healthy individuals are still relatively rare. Most cases still occur in hospitalized patients with other illnesses. However, the incidence in the community is increasing, and this is causing the alarm. Theoretically, any break in the skin, including an open molluscum lesion, could put your child at risk for MRSA. But please be assured, the chances of your child getting MRSA from molluscum are EXTREMELY small.

A team of investigators in Australia lead by 2 of the world's leading scientific experts on the medicinal properties of M. alternifolia (tea tree oil), Dr's Riley and Carson, have shown that high quality tea tree oil found in ZymaDerm was effective in killing ALL of the MRSA strains tested (see summary below). In addition, iodine as found in ZymaDerm is effective in killing ALL bacteria on the skin, WITHOUT EXCEPTION. This is why iodine is used before surgery and as an antiseptic in hopsitals. Then why can't you treat MRSA infection with iodine? Once a person has a MRSA infection, it is DEEP INSIDE the skin and no topical will treat it well. The topicals are to help PREVENT infection. Your bottom line best bet for your child's molluscum is ZymaDerm, both for getting rid of the molluscum and to help prevent any secondary skin infection such as MRSA.

 

J Antimicrob Chemother. 1995 Mar;35(3):421-4.

Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia.

Carson CF, Cookson BD, Farrelly HD, Riley TV.

Department of Microbiology, University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands.

All 66 isolates of Staphylococcus aureus tested were susceptible to the essential oil of Melaleuca alternifolia, or tea tree oil, in disc diffusion and modified broth microdilution methods. Of the isolates tested, 64 were methicillin-resistant S. aureus (MRSA) and 33 were mupirocin-resistant. The MIC and MBC for 60 Australian isolates were 0.25% and 0.50%, respectively. Comparable results were obtained by co-workers in Britain using similar methods.

Other scientific studies on the use of ZymaDerm ingredients have also been recently published and we wil be posting this in the near future. For now, know that ZymaDerm will effectively treat your child's molluscum, and help prevent against possible infection by MRSA. It is the best proven agent for your molluscum.